BenevolentAI uses cognitive computing, semantic search to speed development of in-licensed drugs 

A key ambition of BenevolentAI is to use artificial intelligence to revolutionize the drug development process. Now, with a licensing agreement with Janssen, it is one significant step closer to realizing that dream.

Source: BenevolentAI looks to artificial intelligence for speedy development of in-licensed drugs | FierceBiotech

Leave a Reply

Please log in using one of these methods to post your comment:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

close-alt close collapse comment ellipsis expand gallery heart lock menu next pinned previous reply search share star